Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias
- PMID: 32668612
- PMCID: PMC7404345
- DOI: 10.3390/ijms21144936
Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias
Abstract
In the last years, different kinds of limbic encephalitis associated with autoantibodies against ion channels and synaptic receptors have been described. Many studies have demonstrated that such autoantibodies induce channel or receptor dysfunction. The same mechanism is discussed in immune-mediated cerebellar ataxias (IMCAs), but the pathogenesis has been less investigated. The aim of the present review is to evaluate what kind of cerebellar ion channels, their related proteins, and the synaptic machinery proteins that are preferably impaired by autoantibodies so as to develop cerebellar ataxias (CAs). The cerebellum predictively coordinates motor and cognitive functions through a continuous update of an internal model. These controls are relayed by cerebellum-specific functions such as precise neuronal discharges with potassium channels, synaptic plasticity through calcium signaling pathways coupled with voltage-gated calcium channels (VGCC) and metabotropic glutamate receptors 1 (mGluR1), a synaptic organization with glutamate receptor delta (GluRδ), and output signal formation through chained GABAergic neurons. Consistently, the association of CAs with anti-potassium channel-related proteins, anti-VGCC, anti-mGluR1, and GluRδ, and anti-glutamate decarboxylase 65 antibodies is observed in IMCAs. Despite ample distributions of AMPA and GABA receptors, however, CAs are rare in conditions with autoantibodies against these receptors. Notably, when the autoantibodies impair synaptic transmission, the autoimmune targets are commonly classified into three categories: release machinery proteins, synaptic adhesion molecules, and receptors. This physiopathological categorization impacts on both our understanding of the pathophysiology and clinical prognosis.
Keywords: anti-GAD 65 antibody; anti-metabotropic glutamate receptor 1 antibody; anti-voltage-gated Ca channel antibody; autoantibodies; cerebellar ataxias; immune-mediated cerebellar ataxias.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Cerebellar long-term depression and auto-immune target of auto-antibodies: the concept of LTDpathies.Mol Biomed. 2021 Jan 10;2(1):2. doi: 10.1186/s43556-020-00024-x. Mol Biomed. 2021. PMID: 35006439 Free PMC article. Review.
-
Advances in the Pathogenesis of Auto-antibody-Induced Cerebellar Synaptopathies.Cerebellum. 2023 Feb;22(1):129-147. doi: 10.1007/s12311-021-01359-z. Epub 2022 Jan 22. Cerebellum. 2023. PMID: 35064896 Free PMC article. Review.
-
Recent advances in diagnosis of immune-mediated cerebellar ataxias: novel concepts and fundamental questions on autoimmune mechanisms.J Neurol. 2024 Oct;271(10):7046-7053. doi: 10.1007/s00415-024-12596-7. Epub 2024 Jul 25. J Neurol. 2024. PMID: 39052041 Review.
-
Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.J Neural Transm (Vienna). 2014 Aug;121(8):1029-75. doi: 10.1007/s00702-014-1193-3. Epub 2014 Aug 1. J Neural Transm (Vienna). 2014. PMID: 25081016 Review.
-
[Immune-Mediated Cerebellar Ataxias].Brain Nerve. 2023 Jun;75(6):737-747. doi: 10.11477/mf.1416202409. Brain Nerve. 2023. PMID: 37287357 Japanese.
Cited by
-
The Clinical Concept of LTDpathy: Is Dysregulated LTD Responsible for Prodromal Cerebellar Symptoms?Brain Sci. 2022 Feb 24;12(3):303. doi: 10.3390/brainsci12030303. Brain Sci. 2022. PMID: 35326260 Free PMC article.
-
Neuromyotonia: a skin-deep problem.BMJ Case Rep. 2022 Apr 11;15(4):e237959. doi: 10.1136/bcr-2020-237959. BMJ Case Rep. 2022. PMID: 35410943 Free PMC article.
-
Cerebellar long-term depression and auto-immune target of auto-antibodies: the concept of LTDpathies.Mol Biomed. 2021 Jan 10;2(1):2. doi: 10.1186/s43556-020-00024-x. Mol Biomed. 2021. PMID: 35006439 Free PMC article. Review.
-
Neurological Autoimmunity Associated With Homer-3 Antibody: A Case Series From China.Neurol Neuroimmunol Neuroinflamm. 2021 Sep 27;8(6):e1077. doi: 10.1212/NXI.0000000000001077. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34580182 Free PMC article.
-
GAD65 Antibody-Associated Neurologic Syndrome Overlapping Hemophagocytic Lymphohistiocytosis.CNS Neurosci Ther. 2025 Mar;31(3):e70364. doi: 10.1111/cns.70364. CNS Neurosci Ther. 2025. PMID: 40152056 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources